Hartford Financial Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Hartford Financial Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72K	Buy	+455	New	+$61.5K	0.02%	178
2021 Q1	–	Sell	-40	Closed	-$6K	–	395
2020 Q4	$6K	Buy	+40	New	+$5.12K	﹤0.01%	309

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Hartford Financial Management's XBI Position: Q2 2026 in Review

Hartford Financial Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 455 shares worth $72K. The stake represents 0.02% of the portfolio and ranks #178 among its holdings. This is a return to the name: Hartford Financial Management previously reported a position in XBI as recently as Q4 2020.

Hartford Financial Management first reported a position in XBI in Q4 2020 and has held it in 2 quarters since. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Hartford Financial Management held 455 shares of State Street SPDR S&P Biotech ETF worth $72K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Hartford Financial Management position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.02% of Hartford Financial Management's portfolio in Q2 2026, its #178 holding.
Hartford Financial Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 2 quarters since.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Hartford Financial Management's 13F filing for Q2 2026, filed 24 Jul 2026.